Last checked at 6 Feb 2015 17:02
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades5,838
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals2
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,599.00
Bid:
1,599.50
Ask:
1,600.00
Change:
15.50 (0.98%)
Spread:
0.50 (0.031%)
Open:
1,579.50
High:
1,600.00
Low:
1,575.00
Prev. Close:
1,583.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.6 Feb 2015 12:37
BUZZ-GlaxoSmithKline Plc: Positive data on melanoma drug
** UK-based drugmaker's shares up 1.8 pct at 1528.16 pence on the London Stock Exchange; U.S.-listed shares up 2.11 pct at $46.92 premarket ** Company says melanoma drug, which combines two of GSK's approved treatments, significantly reduced risk of death in post-approval study ** Th
Read more6 Feb 2015 08:14
6 Feb 2015 07:26
GSK hails positive results in melanoma study ahead of FDA approval
Glaxosmithkline (GSK) has announced positive overall survival results from a study of its treatment for patients with 'mutation-positive metastatic melanoma'. The COMBI-d study showed a "statistically significant reduction in the risk of death" for the combination of dabrafenib (Tafinlar) and tramet
Read more5 Feb 2015 11:12